نتائج البحث - "Cortinovis, A."

1

دورية أكاديمية

Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program

المساهمون: Passiglia, Francesco, Lucia Reale, Maria, Lo Russo, Giuseppe, Pasello, Giulia, Minuti, Gabriele, Bulotta, Alessandra, Galetta, Domenico, Pelizzari, Giacomo, Sini, Claudio, Bria, Emilio, Roca, Elisa, Pilotto, Sara, Genova, Carlo, Metro, Giulio, Citarella, Fabrizio, Chiari, Rita, Cortinovis, Diego, Delmonte, Angelo, Russo, Alessandro, Tiseo, Marcello, Cerea, Giulio, Carta, Annamaria, Scotti, Vieri, Vavalà, Tiziana, Brambilla, Marta, Buffoni, Lucio, Buosi, Roberta, Catania, Chiara, Gori, Stefania, Grisanti, Salvatore, Agustoni, Francesco, Garbo, Edoardo, Malapelle, Umberto, Novello, Silvia

مصطلحات موضوعية: KRASp.G12C, Non-small cell lung cancer, Sotorasib, Targeted therapy

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/38157806; volume:187; firstpage:107444; journal:LUNG CANCER; https://hdl.handle.net/11577/3503269Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85181527265

الإتاحة: https://doi.org/10.1016/j.lungcan.2023.107444Test
https://hdl.handle.net/11577/3503269Test

View record in BASE

2

دورية أكاديمية

RET-MAP: An international multi-center study on clinicobiologic features and treatment response in patients with lung cancer harboring a RET fusion

المؤلفون: Aldea, Mihaela, Marinello, Arianna, Duruisseaux, Michael, Zrafi, Wael, Conci, Nicole, Massa, Giacomo, Metro, Giulio, Monnet, Isabelle, Gomez, Patricia Iranzo, Tabbo, Fabrizio, Bria, Emilio, Guisier, Florian, Vasseur, Damien, Lindsay, Colin R, Ponce, Santiago, Cousin, Sophie, Citarella, Fabrizio, Fallet, Vincent, Minatta, Jose Nicolas, Eisert, Anna, de Saint Basile, Hortense, Audigier-Valette, Clarisse, Mezquita, Laura, Calles, Antonio, Mountzios, Giannis, Tagliamento, Marco, Masip, Jordi Remon, Raimbourg, Judith, Terrisse, Safae, Russo, Alexandro, Cortinovis, Diego, Rochigneux, Philippe, Pinato, David James, Cortellini, Alessio, Leonce, Camille, Gazzah, Anas, Ghigna, Maria-Rosa, Ferrara, Roberto, Dall'Olio, Filippo Gustavo, Passiglia, Francesco, Ludovini, Vienna, Barlesi, Fabrice, Felip, Enriqueta, Planchard, David, Besse, Benjamin

المساهمون: Aldea, Mihaela, Marinello, Arianna, Duruisseaux, Michael, Zrafi, Wael, Conci, Nicole, Massa, Giacomo, Metro, Giulio, Monnet, Isabelle, Gomez, Patricia Iranzo, Tabbo, Fabrizio, Bria, Emilio, Guisier, Florian, Vasseur, Damien, Lindsay, Colin R, Ponce, Santiago, Cousin, Sophie, Citarella, Fabrizio, Fallet, Vincent, Minatta, Jose Nicola, Eisert, Anna, de Saint Basile, Hortense, Audigier-Valette, Clarisse, Mezquita, Laura, Calles, Antonio, Mountzios, Gianni, Tagliamento, Marco, Masip, Jordi Remon, Raimbourg, Judith, Terrisse, Safae, Russo, Alexandro, Cortinovis, Diego, Rochigneux, Philippe, Pinato, David Jame, Cortellini, Alessio, Leonce, Camille, Gazzah, Ana, Ghigna, Maria-Rosa, Ferrara, Roberto, Dall'Olio, Filippo Gustavo, Passiglia, Francesco, Ludovini, Vienna, Barlesi, Fabrice, Felip, Enriqueta, Planchard, David, Besse, Benjamin

مصطلحات موضوعية: RET fusion, RET inhibitor, chemotherapy, immunotherapy, non-small cell lung cancer

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36646211; volume:Jan 13; issue:S1556-0864(22)01994-3; firstpage:1; lastpage:26; numberofpages:26; journal:JOURNAL OF THORACIC ONCOLOGY; https://hdl.handle.net/2318/1887421Test

الإتاحة: https://doi.org/10.1016/j.jtho.2022.12.018Test
https://hdl.handle.net/2318/1887421Test

View record in BASE

3

دورية أكاديمية

Host immune‐inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer and poor performance status receiving first‐line immunotherapy

المصدر: Thoracic Cancer, Vol 13, Iss 3, Pp 483-488 (2022)

مصطلحات موضوعية: immunotherapy, inflammation, neutrophil‐to‐lymphocyte ratio (NLR), non‐small cell lung cancer, performance status, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1759-7706Test; https://doaj.org/toc/1759-7714Test

الوصول الحر: https://doaj.org/article/c6c73bc779d045abbf30461995e450e6Test

View record in DOAJ

النص الكامل

4

دورية أكاديمية

Host immune-inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD-L1 ≥50% metastatic non-small cell lung cancer and poor performance status receiving first-line immunotherapy

المساهمون: Banna, G. L., Tiseo, M., Cortinovis, D. L., Facchinetti, F., Aerts, J. G. J. V., Baldessari, C., Giusti, R., Bria, E., Grossi, F., Berardi, R., Morabito, A., Catino, A., Genova, C., Mazzoni, F., Gelibter, A., Rastelli, F., Macerelli, M., Chiari, R., Gori, S., Mansueto, G., Citarella, F., Cantini, L., Rijavec, E., Bertolini, F., Cappuzzo, F., De Toma, A., Friedlaender, A., Metro, G., Pensieri, M. V., Porzio, G., Ficorella, C., Pinato, D. J., Cortellini, A., Addeo, A.

مصطلحات موضوعية: immunotherapy, inflammation, neutrophil-to-lymphocyte ratio (NLR), non-small cell lung cancer, performance status

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34939342; info:eu-repo/semantics/altIdentifier/wos/WOS:000733356800001; volume:13; firstpage:483; lastpage:488; numberofpages:6; journal:THORACIC CANCER; https://hdl.handle.net/11567/1073050Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85121523648

الإتاحة: https://doi.org/10.1111/1759-7714.14256Test
https://hdl.handle.net/11567/1073050Test

View record in BASE

5

دورية أكاديمية

Smoking status during first‐line immunotherapy and chemotherapy in NSCLC patients: A case–control matched analysis from a large multicenter study

المؤلفون: Alessio Cortellini, Andrea De Giglio, Katia Cannita, Diego L. Cortinovis, Robin Cornelissen, Cinzia Baldessari, Raffaele Giusti, Ettore D'Argento, Francesco Grossi, Matteo Santoni, Annamaria Catino, Rossana Berardi, Vincenzo Sforza, Giovanni Rossi, Lorenzo Antonuzzo, Vincenzo Di Noia, Diego Signorelli, Alain Gelibter, Mario Alberto Occhipinti, Alessandro Follador, Francesca Rastelli, Rita Chiari, Luigi Della Gravara, Alessandro Inno, Michele De Tursi, Pietro Di Marino, Giovanni Mansueto, Federica Zoratto, Marco Filetti, Michele Montrone, Fabrizio Citarella, Maria Vittoria Pensieri, Marco Russano, Luca Cantini, Olga Nigro, Alessandro Leonetti, Paola Bordi, Gabriele Minuti, Lorenza Landi, Alessandro De Toma, Clelia Donisi, Serena Ricciardi, Maria Rita Migliorino, Valerio Maria Napoli, Gianmarco Leone, Giulio Metro, Giuseppe L. Banna, Alex Friedlaender, Alfredo Addeo, Corrado Ficorella, Giampiero Porzio

المصدر: Thoracic Cancer, Vol 12, Iss 6, Pp 880-889 (2021)

مصطلحات موضوعية: immunotherapy, non‐small cell lung cancer, pembrolizumab, smoking, tobacco, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1759-7706Test; https://doaj.org/toc/1759-7714Test

الوصول الحر: https://doaj.org/article/c7f53a01da6942bfa7ce73222085c5cdTest

View record in DOAJ

النص الكامل

6

RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion

المؤلفون: Mihaela Aldea, Arianna Marinello, Michael Duruisseaux, Wael Zrafi, Nicole Conci, Giacomo Massa, Giulio Metro, Isabelle Monnet, Patricia Gomez Iranzo, Fabrizio Tabbo, Emilio Bria, Florian Guisier, Damien Vasseur, Colin R. Lindsay, Santiago Ponce-Aix, Sophie Cousin, Fabrizio Citarella, Vincent Fallet, Jose Nicolas Minatta, Anna Eisert, Hortense de Saint Basile, Clarisse Audigier-Valette, Laura Mezquita, Antonio Calles, Giannis Mountzios, Marco Tagliamento, Jordi Remon Masip, Judith Raimbourg, Safae Terrisse, Alessandro Russo, Diego Cortinovis, Philippe Rochigneux, David James Pinato, Alessio Cortellini, Camille Leonce, Anas Gazzah, Maria-Rosa Ghigna, Roberto Ferrara, Filippo Gustavo Dall’Olio, Francesco Passiglia, Vienna Ludovini, Fabrice Barlesi, Enriqueta Felip, David Planchard, Benjamin Besse

المساهمون: Institut Català de la Salut, [Aldea M] Department of Medical Oncology, International Center for Thoracic Cancers (CICT), Gustave Roussy, Villejuif, France. Paris-Saclay University, Kremlin-Bicêtre, France. [Marinello A] Department of Medical Oncology, International Center for Thoracic Cancers (CICT), Gustave Roussy, Villejuif, France. Department of Medical Oncology, Humanitas Research Hospital, Milan, Italy. [Duruisseaux M] Respiratory Department and Early Phase, Louis Pradel Hospital, Hospices Civils de Lyon. Cancer Research Center of Lyon (CRCL). Univ Lyon, Lyon, France. [Zrafi W] Department of Biostatistics and Bioinformatics, Gustave Roussy, Villejuif, France. [Conci N] Department of Medical Oncology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) University Hospital of Bologna, Bologna, Italy. [Massa G] Department of Medical Oncology, National Cancer Institut, Milan, Italy. [Gomez Iranzo P, Felip E] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Otros calificadores::Otros calificadores::/genética [Otros calificadores], RET inhibitors, Pulmons - Càncer - Aspectes genètics, Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung [DISEASES], neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas [ENFERMEDADES], chemotherapy, RET fusion, immunotherapy, non-small cell lung cancer, Anomalies cromosòmiques, Oncology, Other subheadings::Other subheadings::/genetics [Other subheadings], aminoácidos, péptidos y proteínas::proteínas::proteínas mutantes::proteínas mutantes quiméricas::proteínas oncogénicas de fusión [COMPUESTOS QUÍMICOS Y DROGAS], Amino Acids, Peptides, and Proteins::Proteins::Mutant Proteins::Mutant Chimeric Proteins::Oncogene Proteins, Fusion [CHEMICALS AND DRUGS]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57f7bd4756ed222514ab170ab21d1c3dTest
https://doi.org/10.1016/j.jtho.2022.12.018Test

7

دورية أكاديمية

Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: a case-control matched analysis from a large multicenter study

المؤلفون: Cortellini, Alessio, De Giglio, Andrea, Cannita, Katia, Cortinovis, Diego L, Cornelissen, Robin, Baldessari, Cinzia, Giusti, Raffaele, D'Argento, Ettore, Grossi, Francesco, Santoni, Matteo, Catino, Annamaria, Berardi, Rossana, Sforza, Vincenzo, Rossi, Giovanni, Antonuzzo, Lorenzo, Di Noia, Vincenzo, Signorelli, Diego, Gelibter, Alain, Occhipinti, Mario, Follador, Alessandro, Rastelli, Francesca, Chiari, Rita, Gravara, Luigi Della, Inno, Alessandro, De Tursi, Michele, Di Marino, Pietro, Mansueto, Giovanni, Zoratto, Federica, Filetti, Marco, Montrone, Michele, Citarella, Fabrizio, Pensieri, Maria Vittoria, Russano, Marco, Cantini, Luca, Nigro, Olga, Leonetti, Alessandro, Bordi, Paola, Minuti, Gabriele, Landi, Lorenza, De Toma, Alessandro, Donisi, Clelia, Ricciardi, Serena, Migliorino, Maria Rita, Napoli, Valerio Maria, Leone, Gianmarco, Metro, Giulio, Banna, Giuseppe L, Friedlaender, Alex, Addeo, Alfredo, Ficorella, Corrado, Porzio, Giampiero

المساهمون: Cortellini, Alessio, De Giglio, Andrea, Cannita, Katia, Cortinovis, Diego L, Cornelissen, Robin, Baldessari, Cinzia, Giusti, Raffaele, D'Argento, Ettore, Grossi, Francesco, Santoni, Matteo, Catino, Annamaria, Berardi, Rossana, Sforza, Vincenzo, Rossi, Giovanni, Antonuzzo, Lorenzo, Di Noia, Vincenzo, Signorelli, Diego, Gelibter, Alain, Occhipinti, Mario, Follador, Alessandro, Rastelli, Francesca, Chiari, Rita, Gravara, Luigi Della, Inno, Alessandro, De Tursi, Michele, Di Marino, Pietro, Mansueto, Giovanni, Zoratto, Federica, Filetti, Marco, Montrone, Michele, Citarella, Fabrizio, Pensieri, Maria Vittoria, Russano, Marco, Cantini, Luca, Nigro, Olga, Leonetti, Alessandro, Bordi, Paola, Minuti, Gabriele, Landi, Lorenza, De Toma, Alessandro, Donisi, Clelia, Ricciardi, Serena, Migliorino, Maria Rita, Napoli, Valerio Maria, Leone, Gianmarco, Metro, Giulio, Banna, Giuseppe L, Friedlaender, Alex, Addeo, Alfredo, Ficorella, Corrado, Porzio, Giampiero

مصطلحات موضوعية: immunotherapy, non-small cell lung cancer, pembrolizumab, smoking, tobacco

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33527756; info:eu-repo/semantics/altIdentifier/wos/WOS:000613554700001; volume:12; issue:6; firstpage:880; lastpage:889; numberofpages:10; journal:THORACIC CANCER; http://hdl.handle.net/11573/1552033Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85100080636

الإتاحة: https://doi.org/10.1111/1759-7714.13852Test
http://hdl.handle.net/11573/1552033Test

View record in BASE

8

دورية أكاديمية

Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study

المساهمون: Cortellini, A., Cannita, K., Tiseo, M., Cortinovis, D. L., Aerts, J. G. J. V., Baldessari, C., Giusti, R., Ferrara, M. G., D'Argento, E., Grossi, F., Guida, A., Berardi, R., Morabito, A., Genova, C., Antonuzzo, L., Mazzoni, F., De Toma, A., Signorelli, D., Gelibter, A., Targato, G., Rastelli, F., Chiari, R., Rocco, D., Gori, S., De Tursi, M., Mansueto, G., Zoratto, F., Filetti, M., Bracarda, S., Citarella, F., Marco, R., Cantini, L., Nigro, O., Buti, S., Minuti, G., Landi, L., Ricciardi, S., Migliorino, M. R., Natalizio, S., Simona, C., De Filippis, M., Metro, G., Adamo, V., Russo, A., Spinelli, G. P., Di Maio, M., Banna, G. L., Friedlaender, A., Addeo, A., Pinato, D. J., Ficorella, C., Porzio, G.

مصطلحات موضوعية: Immunotherapy, Non-small cell lung cancer, PD-L1, Pembrolizumab, Performance statu, Post-progression, Radiation therapy, Radiotherapy

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000645079600003; volume:148; firstpage:24; lastpage:35; numberofpages:12; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/11381/2901092Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85102300170

الإتاحة: https://doi.org/10.1016/j.ejca.2021.02.005Test
http://hdl.handle.net/11381/2901092Test

View record in BASE

9

دورية أكاديمية

Corrigendum to ‘The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer’: [ESMO Open Volume 6, Issue 2, April 2021, 100078] (ESMO Open (2021) 6(2), (S205970292100034X), (10.1016/j.esmoop.2021.100078))

المساهمون: Banna G.L., Cortellini A., Cortinovis D.L., Tiseo M., Aerts J.G.J.V., Barbieri F., Giusti R., Bria E., Grossi F., Pizzutilo P., Berardi R., Morabito A., Genova C., Mazzoni F., Di Noia V., Signorelli D., Gelibter A., Macerelli M., Rastelli F., Chiari R., Rocco D., Gori S., De Tursi M., Di Marino P., Mansueto G., Zoratto F., Filetti M., Montrone M., Citarella F., Marco R., Cantini L., Nigro O., D'Argento E., Buti S., Minuti G., Landi L., Guaitoli G., Lo Russo G., De Toma A., Donisi C., Friedlaender A., De Giglio A., Metro G., Porzio G., Ficorella C., Addeo A.

مصطلحات موضوعية: immunotherapy, non-small cell lung cancer

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34144775; volume:6; issue:3; firstpage:1; lastpage:1; numberofpages:1; journal:ESMO OPEN; https://hdl.handle.net/11585/918674Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85108674542; https://www.esmoopen.com/article/S2059-7029Test(21)00096-X/pdf

الإتاحة: https://doi.org/10.1016/j.esmoop.2021.100137Test
https://hdl.handle.net/11585/918674Test
https://www.esmoopen.com/article/S2059-7029Test(21)00096-X/pdf

View record in BASE

10

دورية أكاديمية

Host immune-inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD-L1 ≥50% metastatic non-small cell lung cancer and poor performance status receiving first-line immunotherapy

المساهمون: Banna, G. L., Tiseo, M., Cortinovis, D. L., Facchinetti, F., Aerts, J. G. J. V., Baldessari, C., Giusti, R., Bria, E., Grossi, F., Berardi, R., Morabito, A., Catino, A., Genova, C., Mazzoni, F., Gelibter, A., Rastelli, F., Macerelli, M., Chiari, R., Gori, S., Mansueto, G., Citarella, F., Cantini, L., Rijavec, E., Bertolini, F., Cappuzzo, F., De Toma, A., Friedlaender, A., Metro, G., Pensieri, M. V., Porzio, G., Ficorella, C., Pinato, D. J., Cortellini, A., Addeo, A.

مصطلحات موضوعية: immunotherapy, inflammation, neutrophil-to-lymphocyte ratio (NLR), non-small cell lung cancer, performance status

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000733356800001; journal:THORACIC CANCER; http://hdl.handle.net/11381/2909036Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85121523648

الإتاحة: https://doi.org/10.1111/1759-7714.14256Test
http://hdl.handle.net/11381/2909036Test

View record in BASE

تنقيح النتائج